ESPR - Esperion Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts1251214
Avg. Estimate-1.42-0.84-6.73-4.82
Low Estimate-1.84-1.56-7.13-8.62
High Estimate-1.051.28-6.35-1.29
Year Ago EPS-1.44-1.73-6.98-6.73
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts741013
Avg. EstimateN/A19.22M10M29.42M
Low EstimateN/AN/AN/AN/A
High EstimateN/A76.88M100M150M
Year Ago SalesN/AN/AN/A10M
Sales Growth (year/est)N/AN/AN/A194.20%
Earnings History12/30/20173/30/20186/29/20189/29/2018
EPS Est.-1.79-1.56-1.72-1.63
EPS Actual-1.44-1.73-1.71-1.86
Difference0.35-0.170.01-0.23
Surprise %19.60%-10.90%0.60%-14.10%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate-1.42-0.84-6.73-4.82
7 Days Ago-1.42-1.37-6.73-5.43
30 Days Ago-1.42-1.3-6.71-5.41
60 Days Ago-1.4-1.36-6.63-5.38
90 Days Ago-1.34-1.3-6.41-5.43
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/A2
Up Last 30 DaysN/AN/AN/A2
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1N/A1N/A
Growth EstimatesESPRIndustrySectorS&P 500
Current Qtr.1.40%N/AN/A0.12
Next Qtr.51.40%N/AN/A0.04
Current Year3.60%N/AN/A0.18
Next Year28.40%N/AN/A0.08
Next 5 Years (per annum)26.60%N/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A